TrialPediatric blood & cancer2014

Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group.

Brenda Weigel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.